Skip to main content
. 2015 Jun 1;9(6):QC01–QC03. doi: 10.7860/JCDR/2015/13687.6125

[Table/Fig-1]:

Association of clinical presentations of endometriosis with staging

Clinical signs and symptoms Stage 1 (of 119) Stage 2 (of 39) Stage 3 (of 11) Stage 4 (of 11) p-value
N(%) OR N(%) OR N(%) OR N(%) OR
Menstrual Irregularity 25 (21.00%) 1.00 4 (10.25%) 0.43 1 (9.09%) 0.38 2 (18.18%) 0.84 0.40 (NS)
Heavy Menstrual flow 12 (10.08%) 1.00 5 (12.82%) 1.31 2 (18.18%) 1.98 3 (27.27%) 3.34 0.36 (NS)
Scant Menstrual flow 6 (5.04%) 1.00 3 (7.69%) 1.57 2 (18.18%) 4.19 1 (9.09%) 1.97 0.39 (NS)
Dysmenorrhea 40 (33.61%) 1.00 23 (58.97%) 2.83 6 (54.54%) 2.37 7 (63.63) 3.45 0.01 *
Dyspareunia 5 (4.20%) 1.00 4 (10.25%) 2.61 3 (27.27%) 8.55 5 (45.45%) 19 <0.01 *
Chronic Pelvic pain 1 (0.84%) 1.00 1 (2.56%) 3.11 1 (9.09%) 11.8 5 (45.45%) 98.33 <0.01 *
Abdominal mass 0 (0.00%) 1.00 0 (0.00%) N/A 0 (0.00%) N/A 0 (0.00%) N/A -
Tenderness 4 (3.36%) 1.00 4 (10.25%) 3.29 6 (54.54%) 34.5 11 (100%) N/A <0.01 *
Adnexal mass 1 (0.84%) 1.00 0 (0.00%) N/A 2 (18.18%) 26.22 6 (54.54%) 141.6 <0.01 *
Restricted Mobility 1 (0.84%) 1.00 3 (7.69%) 9.83 4 (36.36%) 67.42 10 (90.90%) 1180 <0.01 *

(OR represents Odds Ratios. p <0.05 considered to be statistically significant difference Here, NS represents Non-Significant difference between these groups.)